Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00055068 · ClinicalTrials.gov registry record · Phase 3

Family Based Treatment of Early Childhood Obsessive Compulsive Disorder

A Phase 3 study of Obsessive - Compulsive Disorder, sponsored by Rhode Island Hospital.

Completed
Registry status
Phase 3
Development phase
38
Enrollment target
1
Study location

NCT00055068: Completed Phase 3 study of Obsessive - Compulsive Disorder, sponsored by Rhode Island Hospital.

NCT00055068 is a Phase 3 study of Obsessive - Compulsive Disorder that has completed, run by Rhode Island Hospital. The registered enrollment target is 38 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00055068, a Phase 3 study of Obsessive - Compulsive Disorder, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
Phase 3
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate a treatment program for young children with Obsessive Compulsive Disorder (OCD) and their families.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Relaxation Training

Study Locations (1)

Rhode Island

  • Rhode Island Hospital/Brown University - Providence

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2002-03
Est. Completion 2006-02
Phase Phase 3
Rhode Island Hospital

130 total trials

What the finished NCT00055068 record still lists

NCT00055068 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT00055068 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT00055068 about?

NCT00055068 is a clinical study titled "Family Based Treatment of Early Childhood Obsessive Compulsive Disorder". This study will evaluate a treatment program for young children with Obsessive Compulsive Disorder (OCD) and their families.

What is the current status of trial NCT00055068?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 38 participants. The study started on 2002-03. Estimated completion is 2006-02.

What conditions does trial NCT00055068 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT00055068?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Relaxation Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00055068?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00055068 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00055068's enrollment target sits among peer trials

38 53rd of 84 higher than 32 of 84 other Obsessive - Compulsive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00055068, the US trial registry maintained by the National Library of Medicine. NCT00055068 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.